October 27, 2025

Reimagining Antibody Drug Discovery with AI

By focusing on functional activity, Abalone Bio is advancing CB2-targeting antibodies with the potential to transform treatment for fibrosis, neuropathy, and beyond.

The Medicine Maker

October 27, 2025

‘Keep Sports Betting Fun’ — But Can It Be Safe?

Massachusetts tests new ways to curb gambling addiction amid growing calls for national regulation.

KFF Health News

October 27, 2025

How Hormones May Influence Tirzepatide Outcomes

Researchers show how reproductive stage and hormone therapy influence weight-loss outcomes in women treated with tirzepatide.

Conexiant

October 27, 2025

Lower GI mistakes: Postop Crohn's, vaccine gaps, colonoscopy errors

There is no routine colonoscopy. Focus on the basics to reduce the impact of inevitable mistakes, done reliably every time.

Conexiant

October 27, 2025

Get Ready for CPHI: Off-Patent Semaglutide and Sustainability in a Shifting World

It’s showtime in Frankfurt – with around 62,000 attendees expected.

The Medicine Maker

October 27, 2025

Why Open Access May Not Boost Citations

Researchers found that companion open access journals charge high publication fees yet yield fewer citations than traditional journals.

Conexiant

October 27, 2025

MDIs and the Need for Greener Propellants

Regulations are pushing companies to more environmentally friendly propellants, but how should capacity be scaled up?

The Medicine Maker

October 27, 2025

US Approval for Trifocal IOL Innovation 

BVI’s FINEVISION® HP receives FDA approval

The Ophthalmologist

October 27, 2025

Four Steps to Managing Dry Eye Disease in Glaucoma 

Jesús Merayo Lloves explains the importance of addressing OSD in glaucoma management

The Ophthalmologist